Users Online: 1027
Ahead of Print
» Articles published in the past year
To view other articles click corresponding year from the navigation links on the side bar.
Case Report and Literature Review
Letter to Editor
Letters to Editor
Notice of Retraction
Export selected to
Show all abstracts
Show selected abstracts
Export selected to
Add to my list
Treatment Outcome of the Drug-resistant Zoonotic Cutaneous Leishmaniasis by Glucantime
Simindokht Soleimanifard, Reza Arjmand, Sedighe Saberi, Mansoor Salehi, Seyed Hossain Hejazi
Adv Biomed Res
2017, 6:17 (1 March 2017)
species to antimonial drugs has increased. Hence, in the present study
isolates were collected from patients with resistance phenotype and the presence/absence of resistance to Glucantime was investigated.
Materials and Methods:
Samples were taken from 10 cutaneous leishmaniasis (CL) patients who had not responded to chemotherapy with Glucantime. Nested polymerase chain reaction (PCR) was performed to identify the isolated species. Stationary phase promastigotes were added to the grown, adhesive J774 macrophages. Values obtained from standard strain were compared with the test cultures after exposure to the medicine.
, the effects of Glucantime were assessed by comparing the sizes and the parasite burden of the lesions on mouse model.
The results of amplified band on agarose gel demonstrated all samples were
. After exposure to medicine, a reduction of intracellular amastigotes to half was detected.
, the parasite was eliminated in 90% of mice with lesions caused by both isolates of patients and standard
, and their lesions became smaller significantly.
Pentavalent antimonial (SbV) salts are the main component of chemotherapy against leishmaniasis. However, the medicine has been found ineffective. In the present study, isolates from patients with no response to treatment had no significant difference from the standard
strain (as the sensitive strain). Therefore, in patients with resistance phenotype to Glucantime, the parasites did not actually have intrinsic resistance, i.e., environmental and host factors prevented the successful treatment of the disease.
[HTML Full text]
[Mobile Full text]
[Citations (1) ]
[Sword Plugin for Repository]
Month wise articles
Figures next to the month indicate the number of articles in that month
© Advanced Biomedical Research | Published by Wolters Kluwer -
Online since 15 January, 2012